Management of Acute Confusional State in Emergency Setting
The management of acute confusional state (delirium) in emergency settings requires a systematic ABCDE approach (Airway, Breathing, Circulation, Disability, Exposure) with immediate stabilization of vital functions followed by targeted diagnostic workup and treatment of underlying causes. 1
Initial Assessment and Stabilization
- Immediately assess and secure the airway, breathing, and circulation (ABCs) as the first priority in any patient with acute confusional state 2
- Check blood glucose level promptly to rule out hypoglycemia as a reversible cause 2
- Monitor vital signs including oxygen saturation, as hypoxemia can contribute to or worsen confusion 2
- Establish intravenous access for medication administration and fluid resuscitation if needed 1
Rapid Diagnostic Evaluation
- Determine the time of onset and progression of confusion (last known well time) to establish timeline 2
- Use validated screening tools for delirium assessment such as Confusion Assessment Method (CAM) or CAM-ICU for more reliable diagnosis 3
- Perform targeted neurological examination to identify focal deficits that may suggest stroke or other structural lesions 2
- Obtain comprehensive medication history with special attention to recently added medications, opioids, sedatives, and anticholinergics 2
Laboratory and Diagnostic Testing
Order immediate laboratory tests including:
- Complete blood count to identify infection/leukocytosis 4
- Comprehensive metabolic panel with special attention to sodium, as hyponatremia is a frequent factor associated with delirium 4
- Arterial blood gas analysis if respiratory distress is present 1
- Toxicology screen if drug intoxication is suspected 2
Consider neuroimaging (CT or MRI) when:
- Focal neurological signs are present
- History of head trauma
- First episode of confusion with no obvious cause
- Fever without clear source
- History of malignancy 2
Perform lumbar puncture to exclude CNS infection when:
- Fever is present without clear source
- Meningeal signs are present
- Immunocompromised status
- No other obvious cause is identified 2
Treatment Approach
Non-pharmacological Interventions (First Line)
- Implement early reorientation strategies (frequent verbal reorientation, visible clocks, calendars) 3
- Ensure adequate oxygenation and maintain normal physiologic parameters 1
- Correct underlying metabolic disturbances (dehydration, electrolyte abnormalities) 4
- Encourage early mobilization when appropriate 2
- Minimize sensory deprivation or overload (appropriate lighting, reduce excessive noise) 2
- Remove unnecessary medical devices when possible 3
Pharmacological Management
Reserve pharmacological interventions for patients with severe agitation that poses safety risks or prevents essential medical care 2
For agitated patients requiring medication:
For specific causes:
Special Considerations
- In dying patients with acute confusional state, consider a short and limited trial of hydration to rule out dehydration as a precipitating cause 2
- For patients with seizure-related confusion, anti-epileptic drug therapy is indicated if there are high-risk features for recurrence 2
- In systemic lupus erythematosus with acute confusional state, combination of glucocorticoids with immunosuppressive agents is often effective 2
Monitoring and Follow-up
- Implement continuous monitoring of vital signs and neurological status 1
- Reassess mental status regularly using validated tools 3
- Document response to interventions 4
- Patients with unidentified causes of acute confusional state have higher mortality and require closer follow-up 4
Common Pitfalls to Avoid
- Delaying treatment of the underlying cause while focusing only on symptom management 3
- Overlooking medication side effects as potential causes of confusion 2
- Using physical restraints as first-line management, which can worsen agitation and confusion 2
- Administering sedatives without addressing the underlying cause 2
- Failing to recognize that delirium can persist beyond hospital discharge and may lead to long-term cognitive deficits in approximately 25% of patients 3